The 2020 Focused Updates to the Asthma Management Guidelines: A Report from the
National Asthma Education and Prevention Program Coordinating Committee Expert Panel …

Respiratory disorders, especially non-communicable, chronic inflammatory diseases, are
amongst the leading causes of mortality and morbidity worldwide. Respiratory diseases …

This document provides clinical recommendations for the management of severe asthma.
Comprehensive evidence syntheses, including meta-analyses, were performed to …

Background Despite inhaled corticosteroid plus long-acting β 2-agonist (ICS/LABA) therapy,
30–50% of patients with moderate or severe asthma remain inadequately controlled. We …

Severe and Difficult-to-Treat Asthma in Adults | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

Guideline-based management of asthma focuses on disease severity and choosing the
appropriate medical therapy to control symptoms and reduce the risk of exacerbations …

Severe or therapy-resistant asthma is increasingly recognised as a major unmet need. A
Task Force, supported by the European Respiratory Society and American Thoracic Society …

abstract Bronchial asthma is characterized by chronic airway inflammation, which manifests
clinically as variable airway narrowing (wheezes and dyspnea) and cough. Long-standing …

Background Patients with asthma who are inadequately controlled on inhaled corticosteroid–
long-acting β 2-adrenoceptor agonist (ICS–LABA) combinations might benefit from the …

Background To date, no studies have assessed the efficacy of single-inhaler triple therapy in
asthma. Here we report on two studies that compared the single-inhaler extrafine …